Pharma earnings are crushing it while everyone watches AI — buy the quiet healthcare winners
While tech giants dominated the headlines, several healthcare companies just reported blowout quarterly results and lifted their full-year outlooks. These strong reports from completely different corners of the medical sector show investors are rewarding companies with improving fundamentals.
Idea
Big tech earnings have sucked all the oxygen out of the room, but underneath the surface, multiple healthcare companies are posting exceptional results. Bausch Health surged 28% on a genuine business turnaround, Bristol Myers raised its outlook on strong drug sales, and Veracyte beat estimates and lifted guidance. These are three independent data points from different medical sub-sectors — pharmaceuticals, diagnostics, and specialty care — all pointing to robust demand. Because investor attention is fixed on the AI trade, these quiet healthcare winners are flying under the radar, creating an opportunity to buy improving businesses before the broader market notices.